GaldermaDeliversRecord2025ResultsWithNetSalesof5.207BillionUSD,up17.7%atConstantCurrency1,andCoreEBITDA2of1.211billionUSD,Growing18.9%atConstantCurrency
===2026/3/5 16:11:22===
0)
Total Net Indebtedness
2,356
1,822
Appendix 7: Additional modelling metrics
2025 actuals
2026
Non-core adjustments12
40 M USD
(59 M USD including Operating Fx)
30 - 40 M USD
Effective tax rate13
4.0%15
(20.8% excluding one-time benefit)
~ 20%
Core CAPEX, as a percentage of net sales
2.5%
=*=*=*=*=*=
当前为第42/55页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页